The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Enanta Pharmaceuticals Inc. (ENTA) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $12.63. The Enanta Pharmaceuticals Inc. has recorded 3,126 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Enanta Pharmaceuticals to Present Data for EDP-323, its Oral, Once-Daily, L-Protein Inhibitor in Development for the Treatment of Respiratory Syncytial Virus, at the 9th ESWI Influenza Conference.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Enanta Pharmaceuticals Inc. is $276.47M. A total of 0.71 million shares were traded on the day, compared to an average of 389.06K shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, ENTA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 29 BUYs and 24 SELLs from insiders. Insiders purchased 444,863 shares during that period but sold 152,220.
In the most recent transaction, Or Yat Sun sold 13,925 shares of ENTA for 44.45 per share on Mar 15. After the transaction, the Sr. VP & CSO now owns 374,702 company shares. In a previous transaction on Mar 15, MELLETT PAUL J sold 10,440 shares at 44.43 per share. ENTA shares that Treasurer and CFO owns now total 97,556.
Among the insiders who sold shares, Luly Jay R. disposed of 27,912 shares on Mar 13 at a per-share price of $45.16. This resulted in the President and CEO holding 819,810 shares of ENTA after the transaction. In another insider transaction, MELLETT PAUL J sold 5,000 shares at $53.76 per share on Feb 09. Company shares held by the Treasurer and CFO now total 83,463.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for ENTA in the last 3 months, the mean price target is $30.22 with high estimates of $48.00 and low estimates of $14.00. In terms of 52-week highs and lows, ENTA has a high of $62.06 and a low of $11.56.
As of this writing, ENTA has an earnings estimate of -$2.01 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$1.14 per share and a lower estimate of -$2.35. The company reported an EPS of -$1.79 in the last quarter, which was 9.60% higher than expectations of -$1.98.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ENTA’s latest balance sheet shows that the firm has $244.00M in Cash & Short Term Investments as of fiscal 2021. There were $5.33M in debt and $36.17M in liabilities at the time. Its Book Value Per Share was $11.30, while its Total Shareholder’s Equity was $399.43M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENTA is Buy with a score of 3.29.